Zurueck zur Suche

Reporte zur Charge U032668

Verknuepft ueber VAERS_ID mit VAERSDATA, Vax und Symptoms

7Reporte angezeigt
0Todesfaelle
1Hospitalisiert
0Lebensbedrohlich
0Bleibende Schaeden
NY 1 MI 1 WI 1 IN 1 KS 1 FL 1

VAERS 2233660

MERCK & CO. INC. · HEP B (RECOMBIVAX HB) · Charge U032668

schwer
Staat
NY
Alter
2,0
Geschlecht
F
Eingang
14.04.2022
Impfdatum
13.04.2022
Beginn
13.04.2022
Tage bis Beginn
0,0
Dosis
3
Route/Site
IM / RA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: ja Disable: unbekannt ER: ja Erholt: nein
Condition aggravated Endotracheal intubation Enterovirus test positive Human rhinovirus test positive Seizure

Symptomtext

Patient started to have seizures post vaccine administration about 3hrs after vaccine

Weitere VAERSDATA-Felder
Praegender Schweregrund
Seizure
Hospital-Tage
2,0
Labordaten
Patient positive for rhino entero virus. Patient was intubated and now currently extubated.
Aktuelle Erkrankungen
Unknown
Vorgeschichte
History of epilepsy status post surgery. Seizure free for several months before vaccine
Andere Medikamente
-
Allergien
Seasonal
Vorherige Impfungen
-

VAERS 2630073

MERCK & CO. INC. · HEP B (RECOMBIVAX HB) · Charge U032668

gering
Staat
MI
Alter
-
Geschlecht
U
Eingang
10.05.2023
Impfdatum
08.05.2023
Beginn
08.05.2023
Tage bis Beginn
0,0
Dosis
UNK
Route/Site
- / -
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
Expired product administered No adverse event

Symptomtext

no symptomatic side effects were reported; administration of expired RECOMBIVAXHB to a pediatric patient; This spontaneous report was received from a medical assistant and refers to a pediatric patient of an unknown age and gender. The patient's concurrent conditions, concomitant therapies and medical history was not provided. On 08-MAY-2023, the patient was vaccinated with an expired dose of hepatitis b vaccine (recombinant) thimerosal free (RECOMBIVAX HB) pre-filled syringe, intramuscular injection, 5/0.5 mcrg/ml, 0.5 milliliter, once, lot #U032668, expiration date: 24-APR-2023 (administration site, and route of administration were not provided) administered for prophylaxis (expired product administered). The administered vaccine did not have any temperature excursions. No symptomatic side effects were reported (no adverse event).

Weitere VAERSDATA-Felder
Praegender Schweregrund
Expired product administered
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 2629203

MERCK & CO. INC. · HEP B (RECOMBIVAX HB) · Charge u032668

gering
Staat
WI
Alter
-
Geschlecht
F
Eingang
09.05.2023
Impfdatum
09.05.2023
Beginn
09.05.2023
Tage bis Beginn
0,0
Dosis
1
Route/Site
IM / LL
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: ja
Expired product administered

Symptomtext

vaccine expiration date was 4-24-23, vaccine was given on 5-9-23. Coworker got vaccine ready and asked me to give it because she needed to take care of another patient.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Expired product administered
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 2549424

MERCK & CO. INC. · HEP B (RECOMBIVAX HB) · Charge U032668

gering
Staat
IN
Alter
-
Geschlecht
U
Eingang
04.01.2023
Impfdatum
06.12.2022
Beginn
06.12.2022
Tage bis Beginn
0,0
Dosis
UNK
Route/Site
- / -
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
Incorrect dose administered No adverse event Product administered to patient of inappropriate age

Symptomtext

No additional AE reported; Adult patient was administered the pediatric dose (0.5ml) of RECOMBIVAX HB; This spontaneous report was received from a nurse and refers to an adult patient of unknown age and gender. The patient's medical history, concurrent conditions and concomitant therapies were not reported. On 06-DEC-2022, the patient was vaccinated with hepatitis b vaccine (recombinant) (RECOMBIVAX HB) intramuscular injection, pediatric dose of 0.5 milliliter (Incorrect dose administered), lot #U032668, expiration date: 24-APR-2023, administered for prophylaxis (strength, and route of administration were not provided). No additional adverse events were reported.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Incorrect dose administered
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 2467487

GLAXOSMITHKLINE BIOLOGICALS · HEP B (ENGERIX-B) · Charge U032668

gering
Staat
KS
Alter
13,0
Geschlecht
M
Eingang
03.10.2022
Impfdatum
03.10.2022
Beginn
03.10.2022
Tage bis Beginn
0,0
Dosis
3
Route/Site
SC / LA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: ja
Incorrect dose administered No adverse event

Symptomtext

child was administered the wrong dose of vaccine - no reactions

Weitere VAERSDATA-Felder
Praegender Schweregrund
Incorrect dose administered
Hospital-Tage
-
Labordaten
none
Aktuelle Erkrankungen
N/A
Vorgeschichte
N/A
Andere Medikamente
N/A
Allergien
N/A
Vorherige Impfungen
-

VAERS 2293873

MERCK & CO. INC. · HEP B (RECOMBIVAX HB) · Charge U032668

gering
Staat
FL
Alter
0,1
Geschlecht
U
Eingang
25.05.2022
Impfdatum
16.05.2022
Beginn
16.05.2022
Tage bis Beginn
0,0
Dosis
UNK
Route/Site
- / -
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
No adverse event Product storage error

Symptomtext

No additional AE's reported; HBP reporting AE for improperly stored administered vaccine.; This spontaneous report has been received from a office manager and refers to a 4-week-old patient of unknown gender. The patient's pertinent medical history, previous drugs reactions or allergies, and concomitant medications were not reported. On 16-MAY-2022, the patient was vaccinated with an improperly stored hepatitis b vaccine (recombinant) (RECOMBIVAX HB) intramuscular injection, administered for prophylaxis (lot number U032668, which was confirmed to be valid, and expiration date: 24-APR-2023) (dose, vaccination scheme frequency, anatomical location and route of administration were not provided). The administered dose of the vaccine experienced a temperature excursion of 28 degrees Fahrenheit for 96 hours (product storage error). No previous temperature excursion was reported. No additional adverse event was reported. This is one of several reports received from the same reporter. ; Sender's Comments: US-009507513-2205USA005673:case number 02168906 US-009507513-2205USA005621:case number 02168912

Weitere VAERSDATA-Felder
Praegender Schweregrund
No adverse event
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 2084629

MERCK & CO. INC. · HEP B (RECOMBIVAX HB) · Charge U032668

gering
Staat
-
Alter
-
Geschlecht
F
Eingang
03.02.2022
Impfdatum
-
Beginn
-
Tage bis Beginn
-
Dosis
UNK
Route/Site
- / -
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
Accidental exposure to product Exposure via blood Haemorrhage Skin laceration Syringe issue

Symptomtext

she took the syringe out of the tray and noted the flange was broken; the broken syringe cut ther finger and she had blood; the broken syringe cut ther finger and she had blood; the broken syringe cut ther finger and she had blood; This spontaneous report was received from a health professional via a company representative and refers to a female patient of unknown age. No information regarding patient's medical history, concurrent conditions or concomitant therapies was provided. On an unknown date, the patient worked with a box of hepatitis b vaccine (recombinant) thimerosal free (RECOMBIVAX HB) where one of the syringes was broken (Syringe issue). The patient reached to grab it when she cut her finger on the syringe (Skin laceration and Accidental exposure to product). It was reported in regard to the incident that "She took the syringe out of the tray and noted the flange was broken. The broken syringe cut her finger and she had blood." and also in regard to the question whether the product was administered or exposed to patient's bodily fluids "not administered but caller did get a cut on her finger from broken flange that drew blood" (Exposure via blood). The reported lot# was U032668 and the expiration date was confirmed to be 24-APR-2023. The outcome of these event was unknown.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Accidental exposure to product
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-